This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Spectral AI, Inc. Appoints Erich Spangenberg CEO of Spectral IP, Its Health Care IP-Focused Subsidiary CI
Spectral AI, Inc. Announces Chief Operating Office Changes CI
Spectral AI, Inc. Announces the Appointment of Jeremiah A. Sparks as Chief Commercialization Officer CI
Spectral AI, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Spectral AI, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Transcript : Spectral AI, Inc., Q4 2023 Earnings Call, Mar 27, 2024
Spectral AI, Inc. announced that it expects to receive $30 million in funding CI
Spectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of Deepview? Wound Imaging System CI
Spectral AI, Inc. Announces Intellectual Property Subsidiary to Focus on the Broader AI Healthcare Ecosystem CI
Spectral AI Names Peter Carlson Chief Executive Officer; Reaffirms 2024 Preliminary Revenue Guidance MT
Spectral AI, Inc. Announces Chief Executive Officer Changes CI
Spectral AI, Inc. Announces Management Changes CI
Spectral AI, Inc. Appoints Vincent S. Capone as Chief Financial Officer CI
Spectral AI, Inc. Re-Affirms Revenue Guidance for the Full Year 2024 CI
Spectral AI, Inc. Receives UKCA Authorization for Burn Indication Expected Commercialization Second Half 2024 CI
Spectral AI, Inc. Announces Board Changes CI
Spectral AI Expects Positive Results From Predictive Diagnostic Device -- Shares Decline MT
Spectral AI, Inc. Announces Resignation of Michael Murphy as Director CI
Top Premarket Gainers MT
BTIG Initiates Spectral AI at Buy Rating With $4 Price Target MT
Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI for Burn Injuries CI
Spectral AI, Inc. announced that it expects to receive $10 million in funding from B. Riley Principal Capital II, LLC CI
Spectral AI Names Peter M. Carlson CFO MT
Spectral AI, Inc. Announces Chief Financial Officer Changes CI
Spectral AI, Inc.(NasdaqCM:MDAI) added to S&P TMI Index CI
Chart Spectral AI, Inc.
More charts
Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid health care providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. MDAI Stock
  4. SMD Stock
  5. News Spectral AI, Inc.
  6. Spectral MD : Earnings Flash (SMD.L) SPECTRAL MD HOLDINGS Posts H1 Revenue $7M